Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Biliary Tract Neoplasms × atezolizumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Ovarian Neoplasms 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Esophageal Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 10 Cisplatin 7 S 1 (combination) 6 titanium silicide 2 Oxaliplatin 2 spartalizumab 1 pembrolizumab 1 pamiparib 1 atezolizumab 1 World Health Organization oral rehydration solution 1 Temozolomide 1 Paclitaxel 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03818997 2020-02-05

DYNAMIC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡